{"id":"W2588229474","doi":"10.1093/annonc/mdw435.09","title":"CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"North Carolina GlaxoSmithKline Foundation","keywords":"Medicine; Dabrafenib; Trametinib; Internal medicine; Rash; Adverse effect; Refractory (planetary science); Oncology; Gastroenterology; Cancer; Kinase; Vemurafenib; MAPK/ERK pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002593421,0.0001673831,0.0004982404,0.0003367415,0.00004779362,0.000002810641,0.0002067098,0.0000857904,0.00009861009],"category_scores_gemma":[0.0003737766,0.00007314676,0.00006185866,0.0005378907,0.0001797426,0.00009034426,0.00008699667,0.0001893165,0.00001912528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006354023,"about_ca_system_score_gemma":0.0003642912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001086461,"about_ca_topic_score_gemma":0.001220543,"domain_scores_codex":[0.9981674,0.0002117315,0.0004465419,0.0002918894,0.0004852325,0.0003972145],"domain_scores_gemma":[0.9981915,0.0007122289,0.0002937972,0.0004299634,0.000226172,0.0001463258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.009261089,0.01884139,0.9592278,0.00008012132,0.0001694426,0.001070822,0.0007414665,0.000001545636,0.0005189004,0.000009690582,0.001132672,0.008945033],"study_design_scores_gemma":[0.01851579,0.04814379,0.9294794,0.00008326391,0.00008223276,0.00001726348,0.0001836106,9.930638e-7,0.00237419,0.00002106937,0.001017821,0.00008052197],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956088,0.00006320197,5.742851e-7,0.002768762,0.00006636716,0.001055451,0.00002214216,0.00001366393,0.000401059],"genre_scores_gemma":[0.9993,0.0001850452,0.00001151738,0.000200817,0.00004757606,0.00005552457,0.000003607657,0.00002417159,0.0001717528],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02974837,"threshold_uncertainty_score":0.2982838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05040336938385071,"score_gpt":0.354387140936592,"score_spread":0.3039837715527413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}